Compare NBIX & BNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NBIX | BNT |
|---|---|---|
| Founded | 1992 | 2020 |
| Country | United States | Bermuda |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.2B | 11.8B |
| IPO Year | 1996 | N/A |
| Metric | NBIX | BNT |
|---|---|---|
| Price | $131.90 | $46.64 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 22 | 0 |
| Target Price | ★ $180.82 | N/A |
| AVG Volume (30 Days) | ★ 1.0M | 26.4K |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 0.60% |
| EPS Growth | ★ 41.95 | N/A |
| EPS | ★ 4.67 | N/A |
| Revenue | ★ $161,626,000.00 | N/A |
| Revenue This Year | $24.73 | N/A |
| Revenue Next Year | $13.14 | N/A |
| P/E Ratio | $28.58 | ★ $19.14 |
| Revenue Growth | ★ 977.51 | N/A |
| 52 Week Low | $100.83 | $40.06 |
| 52 Week High | $160.18 | $74.16 |
| Indicator | NBIX | BNT |
|---|---|---|
| Relative Strength Index (RSI) | 51.80 | 67.87 |
| Support Level | $124.29 | $44.62 |
| Resistance Level | $136.23 | $47.95 |
| Average True Range (ATR) | 4.36 | 1.09 |
| MACD | 0.20 | 0.67 |
| Stochastic Oscillator | 72.29 | 86.88 |
Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.
Brookfield Wealth Solutions Ltd, formerly Brookfield Reinsurance Ltd operates a capital solutions business providing insurance and reinsurance services to individuals and institutions. Through its subsidiary, the company offers a broad range of insurance products and services, including life insurance and annuities, and personal and commercial property and casualty insurance. It is organized into three reporting segments: Direct Insurance, Reinsurance, and Pension Risk Transfer (PRT).